Transplantation outcomes for severe combined immunodeficiency, 2000-2009

New England Journal of Medicine

Volumn 371, Issue 5, 2014, Pages 434-446

  Pai, Sung Yun ^a,c   Logan, Brent R ^d   Griffith, Linda M ^f   Buckley, Rebecca H ^g   Parrott, Roberta E ^g   Dvorak, Christopher C ^h   Kapoor, Neena ⁱ   Hanson, Imelda C ^j   Filipovich, Alexandra H ^k   Jyonouchi, Soma ^l   Sullivan, Kathleen E ^l   Small, Trudy N ^e   Burroughs, Lauri ^m   Skoda Smith, Suzanne ^m   Haight, Ann E ⁿ   Grizzle, Audrey ⁿ   Pulsipher, Michael A ^o   Chan, Ka Wah ^p   Fuleihan, Ramsay L ^q   Haddad, Elie ^r   Loechelt, Brett ^s   Aquino, Victor M ^t   Gillio, Alfred ^u   Davis, Jeffrey ^v   Knutsen, Alan ^x   Smith, Angela R ^y   Moore, Theodore B ^z   Schroeder, Marlis L ^w   Goldman, Frederick D ^aa   Connelly, James A ^ab   Porteus, Matthew H ^ac   Xiang, Qun ^d   Shearer, William T ^j   Fleisher, Thomas A ^f   Kohn, Donald B ^z   Puck, Jennifer M ^h   Notarangelo, Luigi D ^b   Cowan, Morton J ^h   O'Reilly, Richard J ^e   more..

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ CHILDREN S HOSPITAL LOS ANGELES   (United States)

^j BAYLOR COLLEGE OF MEDICINE   (United States)

^k CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^l CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^m SEATTLE CHILDREN S HOSPITAL   (United States)

ⁿ CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^o UNIVERSITY OF UTAH   (United States)

^p TEXAS TRANSPLANT INSTITUTE   (United States)

^q NORTHWESTERN UNIVERSITY   (United States)

^r UNIVERSITY OF MONTREAL   (Canada)

^s CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^t UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^u HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^v BC CHILDREN S HOSPITAL   (Canada)

^w UNIVERSITY OF MANITOBA   (Canada)

^x SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^y UNIVERSITY OF MINNESOTA   (United States)

^z MATTEL CHILDREN S HOSPITAL   (United States)

^aa University of Alabama at Birmingham   (United States)

^ab UNIVERSITY OF MICHIGAN   (United States)

^ac STANFORD UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CYCLOPHOSPHAMIDE; FLUDARABINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; THYMOCYTE ANTIBODY;

ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MEMBRANE RECONSTITUTION; MYELOABLATIVE CONDITIONING; NONMYELOABLATIVE CONDITIONING; PNEUMOCYSTIS JIROVECI; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEVERE COMBINED IMMUNODEFICIENCY; SURVIVAL RATE; SURVIVAL TIME; T CELL DEPLETION; TRANSPLANTATION; WHOLE BODY RADIATION;

ANTIGENS, CD3; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN A; INCIDENCE; INFANT; LYMPHOCYTE COUNT; MALE; RETREATMENT; RETROSPECTIVE STUDIES; SEVERE COMBINED IMMUNODEFICIENCY; SIBLINGS; SURVIVAL RATE; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 84904876386     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1401177     Document Type: Article

References (37)

1. Al-Herz W, Bousfiha A, Casanova J-L, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies expert committee for primary immunodeficiency. Front Immunol 2011;2:54.
2. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968;2:1366-9.
3. O'Reilly RJ, Dupont B, Pahwa S, et al. Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. N Engl J Med 1977;297:1311-8. (Pubitemid 8249122)
4. Reisner Y, Kapoor N, Kirkpatrick D, et al. Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983;61:341-8. (Pubitemid 13137655)
5. Cowan MJ, Wara DW, Weintrub PS, Pabst H, Ammann AJ. Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T-depleted marrow cells. J Clin Immunol 1985;5:370-6. (Pubitemid 16199504)
6. O'Reilly RJ, Brochstein J, Collins N, et al. Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency. Vox Sang 1986;51:Suppl 2:81-6. (Pubitemid 16011426)
7. Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999;340:508-16. (Pubitemid 29093286)
8. Bhattacharya A, Slatter MA, Chapman CE, et al. Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency. Bone Marrow Transplant 2005;36:295-9. (Pubitemid 41195161)
9. Tsuji Y, Imai K, Kajiwara M, et al. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team. Bone Marrow Transplant 2006;37:469-77.
10. Fernandes JF, Rocha V, Labopin M, et al. Transplanting patients with SCID: mismatched related stem cells or unrelated cord blood? Blood 2012;119:2949-55.
11. Sarzotti-Kelsoe M, Win CM, Parrott RE, et al. Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras. Blood 2009;114:1445-53.
12. Buckley RH, Win CM, Moser BK, Parrott RE, Sajaroff E, Sarzotti-Kelsoe M. Post-transplantation B cell function in different molecular types of SCID. J Clin Immunol 2013;33:96-110.
13. Haddad E, Landais P, Friedrich W, et al. Long-term immune reconstitution and outcome after HLA-nonidentical T-celldepleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood 1998;91:3646-53. (Pubitemid 28225731)
14. Antoine C, Müller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003;361:553-60. (Pubitemid 36207472)
15. Gennery AR, Slatter MA, Grandin L, et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol 2010;126:602-10.
16. Neven B, Leroy S, Decaluwe H, et al. Long-term outcome after haematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency: long-term outcome of HSCT in SCID. Blood 2009;113:4114-24.
17. Railey MD, Lokhnygina Y, Buckley RH. Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis. J Pediatr 2009;155(6):834.e1-840.e1.
18. Puck JM, SCID Newborn Screening Working Group. Population-based newborn screening for severe combined immunodeficiency: steps toward implementation. J Allergy Clin Immunol 2007;120:760-8. (Pubitemid 47542285)
19. Routes JM, Grossman WJ, Verbsky J, et al. Statewide newborn screening for severe T-cell lymphopenia. JAMA 2009;302:2465-70.
20. Comeau AM, Hale JE, Pai S-Y, et al. Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency. J Inherit Metab Dis 2010;33:Suppl 2:S273-S281.
21. Kwan A, Church JA, Cowan MJ, et al. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. J Allergy Clin Immunol 2013;132:140-50.
22. Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 2002;99:872-8. (Pubitemid 34525548)
23. Buckley RH. Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes. Immunol Res 2011;49:25-43.
24. Brown L, Xu-Bayford J, Allwood Z, et al. Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening. Blood 2011;117:3243-6.
25. Griffith LM, Cowan MJ, Kohn DB, et al. Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. J Allergy Clin Immunol 2008;122:1087-96.
26. Shearer WT, Dunn E, Notarangelo LD, et al. Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol 2013;133:1092-8.
27. Comans-Bitter WM, de Groot R, van den Beemd R, et al. Immunophenotyping of blood lymphocytes in childhood: reference values for lymphocyte subpopulations. J Pediatr 1997;130:388-93. (Pubitemid 27492682)
28. Shearer WT, Rosenblatt HM, Gelman RS, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 2003;112:973-80. (Pubitemid 37412068)
29. Müller SM, Ege M, Pottharst A, Schulz AS, Schwarz K, Friedrich W. Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood 2001;98:1847-51.
30. Dvorak CC, Hung G-Y, Horn B, Dunn E, Oon C-Y, Cowan MJ. Megadose CD34(+) cell grafts improve recovery of T cell engraftment but not B cell immunity in patients with severe combined immunodeficiency disease undergoing haplocompatible nonmyeloablative transplantation. Biol Blood Marrow Transplantation 2008; 14:1125-33.
31. Dvorak CC, Cowan MJ, Logan BR, et al. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the Primary Immune Deficiency Treatment Consortium prospective study 6901. J Clin Immunol 2013;33:1156-64.
32. Cavazzana-Calvo M, Carlier F, Le Deist F, et al. Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype. Blood 2007;109:4575-81. (Pubitemid 46743429)
33. Haddad E, Leroy S, Buckley RH. B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment? J Allergy Clin Immunol 2013;131:994-1000.
34. Cavazzana-Calvo M, André-Schmutz I, Fischer A. Haematopoietic stem cell transplantation for SCID patients: where do we stand? Br J Haematol 2013;160:146-52.
35. Sanders JE. Endocrine complications of high-dose therapy with stem cell transplantation. Pediatr Transplant 2004;8:Suppl 5:39-50. (Pubitemid 38787575)
36. Borgmann-Staudt A, Rendtorff R, Reinmuth S, et al. Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence. Bone Marrow Transplant 2012;47:271-6.
37. Titman P, Pink E, Skucek E, et al. Cognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies. Blood 2008;112:3907-13.